2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Polyclonal Cellular Immune Function is Dose-Dependently Inhibited by Immunosuppressive Drugs but Has Limited Value in Predicting Infection or Rejection Episodes

S. Marx,¹ C. Adam,² S. Leyking,² U. Sester,² M. Sester.
Polymorphisms of Nucleotide Factor of Activated T Cells Cytoplasmic 2 and 4 and the Risk of Acute Rejection Following Kidney Transplantation

Z. Wang, Z. Han, J. Tao, H. Chen, L. Sun, R. Tan, M. Gu.
Population-Based Modeling of Prototypes and Determinants of Allograft Function Trajectories after Kidney Transplantation: Implications for Patient Monitoring and Risk Stratification

M. Raynaud, O. Aubert, M. Naessens, E. Morelon, M. Giral, N. Kamar, E. Wong, S. Jordan, B. Orandi, D. Segev, M. Stegal, P. Reese, C. Lefaucheur, A. Loupy.
Portal Vein Flow as an Indicator of Liver Transplantation for Acute Liver Failure

C-.H. Cheng,¹ C. Lee,² Y-.C. Wang,¹ T-.H. Wu,¹ C-.F. Lee,¹ T-.J. Wu,¹ H. Chou,¹ K-.M. Chan,¹ W-.C. Lee.¹
Portal Vein Thrombosis (PVT) in Liver Transplantation – Recent Experience

D. Bruce, H. Bohorquez, J. Seal, A. Cohen, E. Bugeaud, I. Carmody, D. Sonnier, A. Mathur, L. De Gregorio, H. Sharma, G. Loss.
Positive Implications of an Enhanced Recovery after Surgery Protocol Using Liposomal Bupivacaine for Transverse Abdominis Plane Block in the Perioperative Phase of Robotic Assisted Laparoscopic Living Donor Nephrectomy

A. Nickkholgh,¹ A. Agarwal,¹ B. Sarosiek,² A. Sites,³ A. Nishio Lucar,⁴ J. Oberholzer,¹ P. Amato.⁵
Positive Relationship between Transplant Center Volume and Utilization of Hard to Place Liver Allografts after Late Declines

J. Knox,¹ H. Braun,¹ S. Syeed,¹ K. Halazun,² G. Roll.¹
Post Reperfusion Portal Flow Rate Impacts Liver Allograft and Patient Survival in Patients with Pre Transplant Portal Vein Thrombosis

M. Rizzari, M. Safwan, M. Sobolic, S. Nagai, R. Schilke, K. Collins, A. Yoshida, M. Abouljoud.
Post-Hoc Analysis of Everolimus Trough Levels around the Onset of Related Adverse Events and Treatment Discontinuation in De Novo Kidney Transplant Recipients from the US92 Study

F. Shihab,¹ Y. Qazi,¹ V. Peddi,¹ D. Shaffer,¹ K. McCague,² D. Patel,² S. Mulgaonkar.¹
Post-Transplant High Dose Cyclophosphamide Treatment Induces Thymus-Independent Immune Tolerance of Vascularized Composite Allografts via Complete Depletion of the Alloreactive TCR Repertoire.

G. Furtmüller,¹ B. Oh,¹ J. Sidhom,² M. Fryer,¹ V. Malek,¹ X. Zhou,¹ D. Cooney,¹ C. Brayton,³ J. Dodd-o,⁴ S. Ganguly,² G. Raimondi,¹ W. Lee,¹ L. Luznik,² G. Brandacher.¹

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z